PMA Review Costs Pooled In Unit-Cost Analysis; CDRH To Monitor Modules

FDA's cost study of its device review resources likely will consolidate labor data for traditional, modular, expedited and panel-track PMAs into one cohort, rather than track each application type separately

More from Archive

More from Medtech Insight